IndoUSrare serves as a gateway to the highway-bridges between the USA, and the Indian subcontinent to accelerate research & development of Diagnostics, Drugs, Devices, Biologics, and Therapeutics for rare diseases.
The USA is the largest funder of biomedical research with a forward-looking regulatory framework for innovative new medicines including cell and gene therapies. India is the largest democracy with a genetically diverse population of over 1.3 Billion people. Yet, India accounts for less than 1% of the global clinical research footprint. IndoUSrare will address this gap through enabling education, awareness, advocacy, fostering research collaborations and patient engagement in global clinical trials.
Our Board of Directors:
Harsha K Rajasimha, Ph.D. Founder and Chairman
Sundeep Agrawal, MD, Colt Ventures
Charles Andres, Ph.D., JD, Wilson Sonsini Goodrich Rosati Law Firm
Narayanan Govindarajan, MS, UWorld
Reena Kartha, Ph.D., Center for Orphan Drugs, University of Minnesota
Frank Sasinowski, MS, MPH, JD, Regulatory Attorney, Hyman Phelps McNamara PC and Vice-chair of EveryLife Foundation for rare diseases.
Advisors:
-------------------------------
Stephen Groft, Pharm.D., Board Director of ICORD, Retired Director, NIH, Bethesda, MD
Nicole Boice, Global Genes and RARE-X, Orange County, CA
Ancha Baranova, Professor, George Mason University, Fairfax, VA
Team Members:
Srinivas Seshadri, Director of Roarforrare, SFBayarea
Overview
Mentions in press and media 16
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 8, 2026 | Lead America and Interfaith Communities to Celebrate Unity in Diversity at the Freedom 250 Liberty Gala | Historic American Freedom 250 Liberty Charity Gala - Lead America Announces Interfaith Leadership Alliance Led Community Celebration. Lead America Community Leaders Standing in Solidarity During COVID 19 Pandemic Invitation to Freedom250 Li... |
| Feb 27, 2026 | IndoUSrare's 2030 Vision to Transform Rare Disease Research: Diaspora Engagement, AI Innovation, Patient-Centered Action | Innovation in Rare Diseases: Dr. Kartha in Conversation with Professor Levine #RDDIndoUSrare Virtual Dialogue – February 28, 2026 | 10 AM ET | 8:30 PM IST At IndoUSrare, we work at the intersection of research, patient support, and global c... |
| Dec 19, 2025 | IndoUSrare Announces Winners of Pitch4RARE Startup Pitch Competition Advancing Rare Disease Innovation | IndoUSrare announced GenoPhe Biotech Pvt Ltd and IUVA Labs as the winners of Pitch4RARE 2025. Attox Research Laboratories received special recognition. Pitch4RARE2025 featured an eminent judging panel representing leadership across industry... |
| Oct 29, 2025 | Indo US Bridging RARE Summit 2025 Unites Global Leaders to Accelerate Therapies for Rare Diseases | BridgingRARE Summit 2025 is focused on strengthening the 6 pillars to accelerate diversity and equitable access to rare disease research Meet the 2025 Abbey Meyers Khushi Bridging RARE Award Honorees Only 5 Days to go for the BridgingRARE S... |
| Sep 17, 2025 | IndoUSrare Announces 2025 Abbey Meyers Khushi Bridging RARE Award Honorees | Meet the 2025 Abbey Meyers Khushi Bridging RARE Award Honorees. Join us in person at the Bridging RARE Gala for a celebration of their leadership and impact. Join us in person for the Bridging RARE Gala on the evening of 2nd November 2025. ... |
| Apr 29, 2024 | Newborn Screening Emergency: Urgent Call for Action to Identify 10,000+ Undiagnosed Rare Diseases | RARE PRS #12 The push for a transformative U.S.-India partnership in newborn screening (NBS) sets the stage for a seismic shift in tackling rare diseases, spotlighting the need to prepare for the digital AI revolution in global healthcare. ... |
| Aug 1, 2023 | Asia and the Indian Subcontinent: A Vision for Clinical Studies of Rare Diseases with Varied Prevalence Globally | Clinical Studies of Rare Diseases Without true international collaboration, there will continue to be gaps in global patient registries and incomplete data due to a lack of multicultural sampling of patients, which decelerates the developme... |
| Mar 20, 2023 | Global Registries Could Change the Lives of Hundreds of Millions of Rare Disease Patients Everywhere | While an astounding number of patients are available for clinical trials worldwide, U.S. sponsors of potential treatments often fail to meet their target patient enrollment as they are mostly focused on the U.S. and E.U. markets during the ... |
| Feb 8, 2023 | Celebrating Rare Disease Day and 40 Years of the Orphan Drug Act Advocating for Rare Disease Patients and Their Families | Figure: A collage of selected art4rare submissions from 2021 and 2022 Our vision is to accelerate research and development of diagnostics and therapeutics through education, advocacy, training, research, digital patient engagement, new tech... |
Reviews 0
FAQ about Indousrare
When was Indousrare founded?
Indousrare was founded in 2019.
What has the press written about Indousrare?
Parsers VC has collected 16 articles mentioning Indousrare, among them “Lead America and Interfaith Communities to Celebrate Unity in Diversity at the Freedom 250 Liberty Gala” (Jul 8, 2026) and “IndoUSrare's 2030 Vision to Transform Rare Disease Research: Diaspora Engagement, AI Innovation, Patient-Centered Action” (Feb 27, 2026).
Is Indousrare still active?
Yes, Indousrare is active; its latest activity on Parsers VC dates from Oct 6, 2026.